Publications
Morris, V. K., Ciombor, K. K., Xiao, L., Ochieng, J. K., Marmonti, E., Polite, B., Weinberg, B. A., Krauss, J. C., Hays, J., Mukherjee, S., Aranha, O., Iqbal, S., Shields, T., Benson, A. B., Kazmi, S., Lieu, C., Hochster, H., Whisenant, J., Haymaker, C., & Eng, C. (2026). NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal. Journal of Clinical Oncology. https://doi.org/10.1200/JCO-25-00929
Ozirmak Lermi, N., Molina Ayala, M., Hernandez, S., Lu, W., Khan, K., Serrano, A., Lubo, I., Hamana, L., Tomczak, K., Barnes, S., Dou, J., Liang, Q., Zhang, S., Zhang, Q. C., Zhang, J., Xu, M., Woodman, S. E., Wang, W., Virani, S., … Solis Soto, L. M. (2025). Comparison of imaging based single-cell resolution spatial transcriptomics profiling platforms using formalin-fixed paraffin-embedded tumor samples. Nature Communications, 16(1). https://doi.org/10.1038/S41467-025-63414-1
Morris, V. K., Liu, S., Lin, K., Zhu, H., Prasad, S., Mahvash, A., Bhosale, P., Sun, B., Parra Cuentas, E., Wistuba, I. I., Peddireddy, A., Yao, J., Mendoza-Perez, J., Knafl, M., Woodman, S. E., Eng, C., & Halperin, D. (2025). Phase II trial of atezolizumab and bevacizumab for treatment of HPV-positive unresectable or metastatic squamous cell carcinoma of the anal canal. Clinical Cancer Research, 31(9), 1657–1666. https://doi.org/10.1158/1078-0432.CCR-24-1512
How, J. A., Dang, M., Lee, S., Fellman, B., Westin, S. N., Sood, A. K., Fleming, N. D., Shafer, A., Yuan, Y., Liu, J., Zhao, L., Celestino, J., Hajek, R., Morgan, M. B., Parra, E. R., Laberiano Fernandez, C. D., Arrechedera, C. A., Solis Soto, L. M., Schmeler, K. M., … Jazaeri, A. A. (2025). Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial. Med, 6(1), 100494. https://doi.org/10.1016/J.MEDJ.2024.07.022
Hasanov, M., Kiany, S., Forget, M. A., Bassett, R., Davies, M. A., Diab, A., Gershenwald, J. E., Glitza, I. C., Lee, J. E., Lucci, A., McQuade, J. L., Patel, S. P., Ross, M. I., Tawbi, H. A., Wargo, J. A., Wong, M. K., Bernatchez, C., Hwu, P., Haymaker, C., & Amaria, R. N. (2025). Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma. Oncoimmunology, 14(1). https://doi.org/10.1080/2162402X.2025.2546402
Knisely, A., Dai, Y., Barlow, G. L., Lee, S., Lawson, B., Clark, H., Fellman, B., Yuan, Y., Lu, W., Lubo Julio, I. C., Lazcano, R. N., Chelvanambi, M., Melendez, B., Singh, B., Singh, B., Wani, K., Chen, J., Yeh, C. C., Gao, J., … Jazaeri, A. A. (2025). Surgical and Blood-Based Minimal Residual Disease in Patients with Ovarian Cancer after First-line Therapy: Clinical Outcomes and Translational Opportunities. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 31(19), 4122–4135. https://doi.org/10.1158/1078-0432.CCR-25-0512
Amaria, R., Knisely, A., Vining, D., Kopetz, S., Overman, M. J., Javle, M., Antonoff, M. B., Tzeng, C. W. D., Wolff, R. A., Pant, S., Lito, K., Rangel, K., Fellman, B., Yuan, Y., Lu, K. H., Sakellariou-Thompson, D., Haymaker, C. L., Forget, M. A., Hwu, P., … Jazaeri, A. A. (2024). Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma. Journal for Immunotherapy of Cancer, 12(2), e006822. https://doi.org/10.1136/JITC-2023-006822
Campbell, M. T., Balderrama-Brondani, V., Jimenez, C., Tamsen, G., Marcal, L. P., Varghese, J., Shah, A. Y., Long, J. P., Zhang, M., Ochieng, J., Haymaker, C., & Habra, M. A. (2024). Cabozantinib monotherapy for advanced adrenocortical carcinoma: a single-arm, phase 2 trial. The Lancet Oncology, 25(5), 649–657. https://doi.org/10.1016/S1470-2045(24)00095-0 Gordon, M. J., Feng, L., Strati, P., Lee, H. J., Hagemeister, F. B., Westin, J. R., Samaniego, F., Marques-Piubelli, M. L., Vega Vazquez, F., Parra Cuentas, E. R., Solis-Soto, L. M., Ma, W., Wang, J., Claret, L., Averill, B., Ibanez, K., Fayad, L. E., Flowers, C. R., Green, M. R., … Nastoupil, L. J. (2024). Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study. Cancer, 130(6), 876–885. https://doi.org/10.1002/CNCR.35114
Han, G., Sinjab, A., Rahal, Z., Lynch, A. M., Treekitkarnmongkol, W., Liu, Y., Serrano, A. G., Feng, J., Liang, K., Khan, K., Lu, W., Hernandez, S. D., Liu, Y., Cao, X., Dai, E., Pei, G., Hu, J., Abaya, C., Gomez-Bolanos, L. I., … Kadara, H. (2024). An atlas of epithelial cell states and plasticity in lung adenocarcinoma. Nature, 627(8004), 656–663. https://doi.org/10.1038/s41586-024-07113-9
He, S., Gubin, M. M., Rafei, H., Basar, R., Dede, M., Jiang, X., Liang, Q., Tan, Y., Kim, K., Gillison, M. L., Rezvani, K., Peng, W., Haymaker, C., Hernandez, S., Solis, L. M., Mohanty, V., & Chen, K. (2024). Elucidating immune-related gene transcriptional programs via factorization of large-scale RNA-profiles. IScience, 27(6), 110096. https://doi.org/10.1016/J.ISCI.2024.110096
Lubo, I., Hernandez, S., Wistuba, I. I., & Solis Soto, L. M. (2024). Novel Spatial Approaches to Dissect the Lung Cancer Immune Microenvironment. Cancers, 16(24). https://doi.org/10.3390/CANCERS16244145
Ludmir, E. B., Sherry, A. D., Fellman, B. M., Liu, S., Bathala, T., Haymaker, C., Medina-Rosales, M. N., Reuben, A., Holliday, E. B., Smith, G. L., Noticewala, S. S., Nicholas, S., Price, T. R., Martin-Paulpeter, R. M., Perles, L. A., Lee, S. S., Lee, M. S., Smaglo, B. G., Huey, R. W., … Tang, C. (2024). Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial. Journal of Clinical Oncology. https://doi.org/10.1200/JCO.24.00081/SUPPL_FILE/PROTOCOL_JCO.24.00081.PDF
Parra, E. R., Zhang, J., Duose, D. Y., Gonzalez-Kozlova, E., Redman, M. W., Chen, H., Manyam, G. C., Kumar, G., Zhang, J., Song, X., Lazcano, R., Marques-Piubelli, M. L., Laberiano-Fernandez, C., Rojas, F., Zhang, B., Taing, L., Jhaveri, A., Geisberg, J., Altreuter, J., … Haymaker, C. (2024). Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial. Clinical Cancer Research, 30(8), 1655. https://doi.org/10.1158/1078-0432.CCR-23-0251
Reddy, J. P., Sherry, A. D., Fellman, B., Liu, S., Bathala, T., Haymaker, C., Cohen, L., Smith, B. D., Ramirez, D., Shaitelman, S. F., Chun, S. G., Medina-Rosales, M., Teshome, M., Brewster, A., Barcenas, C. H., Reuben, A., Ghia, A. J., Ludmir, E. B., Weed, D., … Tang, C. (2024). Adding Metastasis-Directed Therapy to Standard-of-Care Systemic Therapy for Oligometastatic Breast Cancer (EXTEND): A Multicenter, Randomized Phase 2 Trial. International Journal of Radiation Oncology*Biology*Physics. https://doi.org/10.1016/J.IJROBP.2024.10.030
Serrano, A. G., Rocha, P., Freitas Lima, C., Stewart, A., Zhang, B., Diao, L., Fujimoto, J., Cardnell, R. J., Lu, W., Khan, K., Sable, B., Ellison, A. R., Wistuba, I. I., Concannon, K. F., Halperin, D. M., Bogdan, C., Sircar, K., Zhang, M., Cargill, K., … Solis Soto, L. M. (2024). Delta-like ligand 3 (DLL3) landscape in pulmonary and extra-pulmonary neuroendocrine neoplasms. Npj Precision Oncology, 8(1), 268. https://doi.org/10.1038/S41698-024-00739-Y